Profile picture

Doctor Abbasin Zegard

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)
Membership: EHRA Member
Follow
Logo ESC

Contributor content

CMR for arrhythmia risk stratification in chronic ischaemic heart disease
Presentation
CMR for arrhythmia risk stratification in chronic ischaemic heart disease
Read more
Intra-operative ultra high-frequency ECG in relation to left ventricular reverse remodelling after cardiac resynchronization therapy
Presentation
Intra-operative ultra high-frequency ECG in relation to left ventricular reverse remodelling after cardiac resynchronization therapy
Read more
Arrhythmic risk stratification in non-ischemic cardiomyopathy using cardiovascular magnetic resonance
Presentation
Arrhythmic risk stratification in non-ischemic cardiomyopathy using cardiovascular magnetic resonance
Read more
Left ventricular ejection fraction and myocardial fibrosis in survivors of ventricular fibrillation and ventricular tachycardia
Presentation
Left ventricular ejection fraction and myocardial fibrosis in survivors of ventricular fibrillation and ventricular tachycardia
Read more
Cardiac resynchronization therapy using endocardial versus trans-coronary sinus, epicardial left ventricular pacing: the Epi-Endo study
Presentation
Cardiac resynchronization therapy using endocardial versus trans-coronary sinus, epicardial left ventricular pacing: the Epi-Endo study
Read more
Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation
Presentation
Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation
Read more
Gray zone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%
Presentation
Gray zone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%
Read more
Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease
Presentation
Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease
Read more
Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%
Presentation
Grayzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction greater than 35%
Read more
Myocardial phenotype of patients with indications for secondary prevention implantable cardioverter defibrillator therapy: insights from cardiovascular magnetic resonance
Presentation
Myocardial phenotype of patients with indications for secondary prevention implantable cardioverter defibrillator therapy: insights from cardiovascular magnetic resonance
Read more

ESC 365 is supported by

novartis Explore sponsored resources